Taysha’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Taysha is a biotechnology firm that develops and commercializes gene therapies for the treatment of monogenic central nervous system disorders. Read more

R.A. Session's photo - President & CEO of Taysha

President & CEO

R.A. Session

CEO Approval Rating

90/100

Founded:

2020

Status:

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Annexon is a top competitor of Taysha. Annexon is a Public company that was founded in 2011 in South San Francisco, California. Annexon operates in the Medical Research & Laboratories industry. Compared to Taysha, Annexon has 5 more employees.

Verge Genomics is seen as one of Taysha's biggest rivals. Verge Genomics was founded in 2015, and is headquartered in South San Francisco, California. Verge Genomics is in the Biotechnology industry. Verge Genomics generates $6M more revenue vs. Taysha.

Axial is seen as one of Taysha's top competitors. Axial was founded in Waltham, Massachusetts} in 2013. Axial competes in the Medical Research & Laboratories industry. Compared to Taysha, Axial generates $1.8M more revenue.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is $ < 1M a good estimate for Taysha's revenue?

Acquisitions

No recent acquisitions found related to Taysha

Taysha Funding History

$125M

Since Taysha was founded in 2020, it has participated in 2 rounds of funding. In total Taysha has raised $125.0M. Taysha's last funding round was on Jul 2020 for a total of $95.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Series B
Jul 2020
$95M

Fidelity Management & Research Company LLC

Seed
Mar 2020
$30M

Total Funding: $125M

Since Taysha was founded in 2020, it has participated in 2 rounds of funding. In total Taysha has raised $125.0M. Taysha's last funding round was on Jul 2020 for a total of $95.0M

Investments

No recent investments found related to Taysha

Taysha News

September 3, 2020Global University Venturing

Taysha tilts toward public markets - Global University Venturing

UT Southwestern-linked CNS disease drug developer Taysha has filed to raise up to $100m in an IPO, ju... See more »
September 2, 2020The Business Journals: Dallas

Dallas' Taysha Gene Therapies - after loading up on more than $100M in funding - files for an IPO

Another North Texas company is looking for a move to the public markets. Dallas' Taysha Gene Therapie... See more »
August 29, 2020Pharmabiz

Taysha Gene receives US FDA orphan drug and rare pediatric disease status for GM2 Gangliosidosis

Taysha Gene Therapies, a patient─centric gene therapy company, announced that it has received Orphan ... See more »
April 29, 2020FinSMEs

Taysha Gene Therapies Raises $30M in Seed Financing

Taysha Gene Therapies, a Dallas, TX-based...... See more »

Taysha Press Releases

Headquarters

7318 Morton Street

Dallas, Texas75209

212-551-8702

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Taysha is a biotechnology firm that develops and commercializes gene therapies for the treatment of monogenic central nervous system disorders. Taysha was founded in 2020. Taysha's headquarters is located in Dallas, Texas, USA 75209. It has raised 125...

CEO

Taysha's President & CEO, R.A. Session, currently has an approval rating of 90%. Taysha's primary competitors are Annexon, Verge Genomics & Axial.

Website

tayshagtx.com

Frequently Asked Questions about Taysha

  1. When was Taysha founded?

    Taysha was founded in 2020
  2. Who is Taysha's CEO?

    Taysha's CEO is R.A. Session
  3. How much revenue does Taysha generate?

    Taysha generates $ < 1M in revenue
  4. How much funding does Taysha have?

    Taysha has historically raised $125M in funding
  1. Where is Taysha's headquarters?

    Taysha's headquarters is in Dallas Texas, USA
  2. How many employees does Taysha have?

    Taysha has 25 employees
  3. What sector does Taysha operate in?

    Taysha is in Biotechnology
  4. Who are Taysha's competitors?

    Taysha's top competitors are Annexon, Verge Genomics, Axial